F Jakob1, S Nitschmann. Show Affiliations » 1. Orthopädisches Zentrum für Muskuloskelettale Forschung, Würzburg, Deutschland. f-jakob.klh@uni-wuerzburg.de
Abstract
Entities: Disease
Mesh: See more » Alendronate/adverse effectsAlendronate/therapeutic useBone Density Conservation Agents/adverse effectsBone Density Conservation Agents/therapeutic useDouble-Blind MethodFemaleGlucocorticoids/adverse effectsGlucocorticoids/therapeutic useHumansMaleMiddle AgedMulticenter Studies as TopicOsteoporosis/chemically inducedOsteoporosis/drug therapyRandomized Controlled Trials as TopicTeriparatide/adverse effectsTeriparatide/therapeutic use
Substances: See more » Bone Density Conservation AgentsGlucocorticoidsTeriparatideAlendronate
Year: 2008 PMID: 19018505 DOI: 10.1007/s00108-008-2255-0
Source DB: PubMed Journal: Internist (Berl) ISSN: 0020-9554 Impact factor: 0.743